Companies/UK/GSK

GSK plc

Income flow

Annual
GSK ANNUAL Income StatementPeriod 2025-12-31Source ANNUAL
Net sales$33B+4% Y/YRevenue$33B+4% Y/YGross profit$24B+6% Y/YCost of revenue$9BOperating profit$8B+97% Y/YOperating expenses$16BNet profit$6B+122% Y/YTax$1BSG&A$9BR&D & other$7B

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).3.92%5y avgAverage dividend yield over the past five years — a smoother view than the latest print.4.11%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0.68PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.56.5%Shares outTotal shares currently outstanding (issued and not retired).2.00BFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).1.94B
Dividend calendar
Ex-dividend
2026-08-14
Pay date
2026-10-08
Last cash
0.452 · 2026-08-14
Stock splits
  1. 1226:10002022-07-22
  2. 8:102022-07-19

Valuation

Trailing PE 35.3 (2025-12-31)PE trend

Fiscal PE3

PeriodEPSClosePE
2025-12-311.3949.0435.3
2024-12-310.6233.8254.4
2023-12-311.237.0630.9

PE = stored close ÷ as-filed diluted EPS (annual 10-K / 20-F). Not a vendor PE series.